MaxCyte Inc
LSE:MXCT
MaxCyte Inc
Gross Profit
MaxCyte Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MaxCyte Inc
LSE:MXCT
|
Gross Profit
$36.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Gross Profit
$17.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
Danaher Corp
NYSE:DHR
|
Gross Profit
$25.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Gross Profit
$2.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Agilent Technologies Inc
NYSE:A
|
Gross Profit
$3.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Gross Profit
$5.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
See Also
What is MaxCyte Inc's Gross Profit?
Gross Profit
36.5m
USD
Based on the financial report for Dec 31, 2023, MaxCyte Inc's Gross Profit amounts to 36.5m USD.
What is MaxCyte Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
20%
Over the last year, the Gross Profit growth was -7%. The average annual Gross Profit growth rates for MaxCyte Inc have been 16% over the past three years , 20% over the past five years .